Quest climbs after raising annual profit forecast

Quest Diagnostics

23/07/2026 15:02

Updates
** Shares of laboratory operator Quest Diagnostics DGX.N rise 10% to $231.20
** Co raises its annual adj. profit forecast to between $11.05 and $11.25 per share, compared to its previous expectation of $10.63 to $10.83
** DGX reports Q2 adj. profit of $3.12 per share vs analysts' average estimate of $2.84 - data compiled by LSEG 
** Co's Q2 revenue of $3.04 billion beats analysts' expectation of $2.97 billion 
** The results were "well above what was widely expected," Barclays analysts said
** "Revenues increased by over 10%, almost all from organic revenue growth across our physician, hospital and consumer channels," says CEO Jim Davis
** Including session's move, stock up ~32% YTD

(Reporting by Christy Santhosh and Sahil Pandey)
((Christy.Santhosh@thomsonreuters.com))